Severe course of Lyme neuroborreliosis in an HIV-1 positive patient; case report and review of the literature

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Van Burgel, Nathalie D ^a   Oosterloo, Mayke ^a   Kroon, Frank P ^a   Van Dam, Alje P ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CEFTRIAXONE; GADOLINIUM; GLUCOSE; IMMUNOGLOBULIN G ANTIBODY; LAMIVUDINE; NEVIRAPINE; PROTEIN; SEROTONIN UPTAKE INHIBITOR; ZIDOVUDINE; ANTIINFECTIVE AGENT;

ADULT; ANTIBODY PRODUCTION; ANXIETY DISORDER; ARTICLE; B LYMPHOCYTE; BORRELIA BURGDORFERI; CASE REPORT; CD4+ T LYMPHOCYTE; CELL POPULATION; CEREBROSPINAL FLUID; CYTOLOGY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAIT; GLAUCOMA; GLUCOSE BLOOD LEVEL; HAND TREMOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERREFLEXIA; HYPERTENSION; IMMUNOPHENOTYPING; ISOELECTRIC FOCUSING; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUMBAR PUNCTURE; LYME DISEASE; MEDICAL HISTORY; MUSCLE STRENGTH; NATURAL KILLER CELL; NETHERLANDS; NEUROLOGIC EXAMINATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT DEPARTMENT; PARAPLEGIA; PHYSICAL EXAMINATION; PLEOCYTOSIS; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; UNSTEADINESS; VIRUS LOAD; BORRELIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MIDDLE AGED; REVIEW;

ANTI-BACTERIAL AGENTS; BORRELIA; CEFTRIAXONE; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; LYME NEUROBORRELIOSIS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 78649483377     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-117     Document Type: Article

References (20)

1. Garcia-Monco JC, Frey HM, Villar BF, Golightly MG, Benach JL. Lyme disease concurrent with human immunodeficiency virus infection. Am J Med 1989, 87:325-328. 10.1016/S0002-9343(89)80158-5, 2773968.
2. Dudle G, Opravil M, Luthy R, Weber R. [Meningitis after acute Borrelia burgdorferi infection in HIV infection]. Dtsch Med Wochenschr 1997, 122:1178-1180. 10.1055/s-2008-1047745, 9378035.
3. Cordoliani F, Vignon-Pennamen MD, Assous MV, Vabres P, Dronne P, Rybojad M, et al. Atypical Lyme borreliosis in an HIV-infected man. Br J Dermatol 1997, 137:437-439. 10.1111/j.1365-2133.1997.tb03754.x, 9349345.
4. Cerny R, Machala L, Bojar M, Rozsypal H, Picha D. Neuroborreliosis in an HIV-1 Positive Patient. Infection 2006, 34:100-102. 10.1007/s15010-006-4134-8, 16703302.
5. Gooskens J, Templeton KE, Claas EC, van Dam AP. Evaluation of an internally controlled real-time PCR targeting the ospA gene for detection of Borrelia burgdorferi sensu lato DNA in cerebrospinal fluid. Clin Microbiol Infect 2006, 12:894-900. 10.1111/j.1469-0691.2006.01509.x, 16882295.
6. Raoult D, Hechemy KE, Baranton G. Cross-reaction with Borrelia burgdorferi antigen of sera from patients with human immunodeficiency virus infection, syphilis, and leptospirosis. J Clin Microbiol 1989, 27:2152-2155. 266983, 2685016.
7. Blatz R, Kuhn HJ, Hermann W, Rytter M, Rodloff AC. [Neurosyphilis and neuroborreliosis. Retrospective evaluation of 22 cases]. Nervenarzt 2005, 76:724-732. 10.1007/s00115-004-1840-2, 15580469.
8. Bockenstedt LK, Kang I, Chang C, Persing D, Hayday A, Barthold SW. CD4+ T helper 1 cells facilitate regression of murine Lyme carditis. Infect Immun 2001, 69:5264-5269. 10.1128/IAI.69.9.5264-5269.2001, 98634, 11500394.
9. Senel M, Rupprecht TA, Tumani H, Pfister HW, Ludolph AC, Brettschneider J. The chemokine CXCL13 in acute neuroborreliosis. J Neurol Neurosurg Psychiatry 2010, 81:929-933. 10.1136/jnnp.2009.195438, 19965843.
10. Widney DP, Breen EC, Boscardin WJ, Kitchen SG, Alcantar JM, Smith JB, et al. Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection. J Interferon Cytokine Res 2005, 25:702-706. 10.1089/jir.2005.25.702, 16318584.
11. Barthold SW, Sidman CL, Smith AL. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg 1992, 47:605-613.
12. Furst B, Glatz M, Kerl H, Mullegger RR. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients. Clin Exp Dermatol 2006, 31:509-514. 10.1111/j.1365-2230.2006.02114.x, 16716151.
13. Karp G, Schlaeffer F, Jotkowitz A, Riesenberg K. Syphilis and HIV co-infection. Eur J Intern Med 2009, 20:9-13. 10.1016/j.ejim.2008.04.002, 19237085.
14. Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 1997, 337:307-314. 10.1056/NEJM199707313370504, 9235493.
15. Jones S, Kim T. Fulminant leptospirosis in a patient with human immunodeficiency virus infection: case report and review of the literature. Clin Infect Dis 2001, 33:E31-E33. 10.1086/322645, 11477534.
16. Baradaran-Dilmaghani R, Stanek G. In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics. Infection 1996, 24:60-63. 10.1007/BF01780660, 8852472.
17. Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 1992, 115(Pt 2):399-423. 10.1093/brain/115.2.399, 1606475.
18. Ljostad U, Skarpaas T, Mygland A. Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol 2007, 14:873-876. 10.1111/j.1468-1331.2007.01799.x, 17662007.
19. Shadick NA, Phillips CB, Logigian EL, Steere AC, Kaplan RF, Berardi VP, et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med 1994, 121:560-567.
20. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990, 323:1438-1444. 10.1056/NEJM199011223232102, 2172819.